Commodore Capital LP 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Commodore Capital LP | 129,041 1.700% |
-138,363 (-51.74%) |
Filing |
| 2022-05-09 4:30 pm Purchase |
2022-04-27 | 13G | Karyopharm Therapeutics Inc. KPTI |
Commodore Capital LP | 267,403 5.100% |
267,403 (New Position) |
Filing |